IDT Australia Ltd
ASX:IDT
IDT Australia Ltd
ASX:IDT
Price:
0.099 AUD
Market Closed
Updated:
May 17, 2024
IDT Australia Ltd
Income from Continuing Operations
|
IDT Australia Ltd
Income from Continuing Operations Peer Comparison
Comparables:
MYX
NEU
BOT
PBP
C
CU6
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
IDT Australia Ltd
ASX:IDT
|
Income from Continuing Operations
-AU$6.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-25%
|
CAGR 10-Years
0%
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Income from Continuing Operations
-AU$317.4m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Income from Continuing Operations
AU$157.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
120%
|
CAGR 10-Years
N/A
|
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Income from Continuing Operations
-AU$14.6m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-24%
|
|
|
Probiotec Ltd
ASX:PBP
|
Income from Continuing Operations
AU$8.7m
|
CAGR 3-Years
14%
|
CAGR 5-Years
17%
|
CAGR 10-Years
15%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Income from Continuing Operations
-AU$24.6m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is IDT Australia Ltd's Income from Continuing Operations?
Income from Continuing Operations
-6.5m
AUD
-6.5m
AUD
Based on the financial report for Dec 31, 2023, IDT Australia Ltd's Income from Continuing Operations amounts to -6.5m AUD.
What is IDT Australia Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
0%
0%
Over the last year, the Income from Continuing Operations growth was 20%.
You don't have any saved screeners yet
